Invesco’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $279K | Buy |
25,324
+2,789
| +12% | +$30.8K | ﹤0.01% | 3394 |
|
|
2025
Q1 | $201K | Sell |
22,535
-23,515
| -51% | -$210K | ﹤0.01% | 3497 |
|
|
2024
Q4 | $433K | Buy |
46,050
+1,576
| +4% | +$14.8K | ﹤0.01% | 3278 |
|
|
2024
Q3 | $358K | Buy |
44,474
+351
| +0.8% | +$2.83K | ﹤0.01% | 3342 |
|
|
2024
Q2 | $374K | Sell |
44,123
-81,778
| -65% | -$693K | ﹤0.01% | 3390 |
|
|
2024
Q1 | $1.13M | Buy |
125,901
+61,215
| +95% | +$549K | ﹤0.01% | 2933 |
|
|
2023
Q4 | $727K | Sell |
64,686
-39,695
| -38% | -$446K | ﹤0.01% | 3026 |
|
|
2023
Q3 | $901K | Buy |
104,381
+51,530
| +98% | +$445K | ﹤0.01% | 2903 |
|
|
2023
Q2 | $547K | Buy |
52,851
+349
| +0.7% | +$3.61K | ﹤0.01% | 3178 |
|
|
2023
Q1 | $570K | Buy |
52,502
+23,900
| +84% | +$259K | ﹤0.01% | 3174 |
|
|
2022
Q4 | $321K | Sell |
28,602
-496
| -2% | -$5.57K | ﹤0.01% | 3460 |
|
|
2022
Q3 | $296K | Buy |
29,098
+2,817
| +11% | +$28.7K | ﹤0.01% | 3500 |
|
|
2022
Q2 | $238K | Buy |
26,281
+373
| +1% | +$3.38K | ﹤0.01% | 3632 |
|
|
2022
Q1 | $248K | Buy |
25,908
+179
| +0.7% | +$1.71K | ﹤0.01% | 3679 |
|
|
2021
Q4 | $284K | Sell |
25,729
-1,523
| -6% | -$16.8K | ﹤0.01% | 3602 |
|
|
2021
Q3 | $202K | Buy |
27,252
+5,440
| +25% | +$40.3K | ﹤0.01% | 3770 |
|
|
2021
Q2 | $317K | Buy |
21,812
+9,508
| +77% | +$138K | ﹤0.01% | 3578 |
|
|
2021
Q1 | $251K | Buy |
12,304
+2,271
| +23% | +$46.3K | ﹤0.01% | 3594 |
|
|
2020
Q4 | $179K | Buy |
+10,033
| New | +$179K | ﹤0.01% | 3522 |
|
|
2020
Q2 | – | Sell |
-25,408
| Closed | -$587K | – | 3641 |
|
|
2020
Q1 | $587K | Buy |
+25,408
| New | +$587K | ﹤0.01% | 2973 |
|
|
2019
Q2 | – | Sell |
-13,190
| Closed | -$299K | – | 3724 |
|
|
2019
Q1 | $299K | Sell |
13,190
-11,788
| -47% | -$267K | ﹤0.01% | 3468 |
|
|
2018
Q4 | $639K | Sell |
24,978
-926
| -4% | -$23.7K | ﹤0.01% | 3153 |
|
|
2018
Q3 | $846K | Buy |
25,904
+3,700
| +17% | +$121K | ﹤0.01% | 3188 |
|
|
2018
Q2 | $504K | Buy |
22,204
+10,695
| +93% | +$243K | ﹤0.01% | 3408 |
|
|
2018
Q1 | $279K | Buy |
11,509
+4,198
| +57% | +$102K | ﹤0.01% | 3514 |
|
|
2017
Q4 | $204K | Sell |
7,311
-49,549
| -87% | -$1.38M | ﹤0.01% | 3525 |
|
|
2017
Q3 | $1.95M | Buy |
56,860
+50,331
| +771% | +$1.72M | ﹤0.01% | 2589 |
|
|
2017
Q2 | $260K | Sell |
6,529
-23
| -0.4% | -$916 | ﹤0.01% | 3525 |
|
|
2017
Q1 | $241K | Sell |
6,552
-36,859
| -85% | -$1.36M | ﹤0.01% | 3564 |
|
|
2016
Q4 | $1.38M | Sell |
43,411
-46,741
| -52% | -$1.49M | ﹤0.01% | 2830 |
|
|
2016
Q3 | $3.27M | Buy |
+90,152
| New | +$3.27M | ﹤0.01% | 2254 |
|
|
2015
Q3 | – | Sell |
-373
| Closed | -$5K | – | 3950 |
|
|
2015
Q2 | $5K | Buy |
+373
| New | +$5K | ﹤0.01% | 4214 |
|